C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2006
10/05/2006	WO2006103300A1 Supplementation for embryo and/or cell manipulation
10/05/2006	WO2006102933A1 Preparation of autologous haematopoietic stem cells, the methods of production, cyropreservation and use for therapy of traumatic diseases of the central nervous system
10/05/2006	WO2006102902A1 A human immortalised neural precursor cell line
10/05/2006	WO2006084229A3 Use of nuclear material to therapeutically reprogram differentiated cells
10/05/2006	WO2006079045A9 Evaluation of salt tolerance in transgenic arabidopsis plants expressing sos2 mutant alleles .
10/05/2006	WO2006069752A3 Device and method for the locally resolved chemical stimulation
10/05/2006	WO2006066049A3 Humanized antibodies that recognize beta amyloid peptide
10/05/2006	WO2005089127A8 Polymer-ceramic-hydrogel composite scaffold for osteochondral repair
10/05/2006	WO2005065341A3 Dry powder cells and cell culture reagents and methods of production thereof
10/05/2006	WO2005056780A8 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23.
10/05/2006	WO2005032344A3 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis
10/05/2006	WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof
10/05/2006	WO2004015065A3 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
10/05/2006	WO2003087306A8 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/05/2006	WO2003086052A3 Low allergen plant and animal genotypes
10/05/2006	WO2003004992A3 Mammalian sweet and amino acid heterodimeric taste receptors
10/05/2006	US20060225159 Canola cultivar NQC02CNX13
10/05/2006	US20060225158 Canola variety SW 013062
10/05/2006	US20060225157 Canola variety SW 013154
10/05/2006	US20060225156 Canola variety SW 013186
10/05/2006	US20060225153 EG1117 and EG307 polynucleotides and uses thereof
10/05/2006	US20060225152 Polynucleotides and methods for making plants resistant to fungal pathogens
10/05/2006	US20060225151 Polynucleotides and methods for making plants resistant to fungal pathogens
10/05/2006	US20060225148 Plastid transit peptides
10/05/2006	US20060225147 DNA fragment which comprises an EPSPS 5' regulatory sequence and a glyphosate-resistant EPSPS coding sequence is introduced into regenerable plant cells; DNA fragment used for transformation preferably comprises modified plant genomic sequence
10/05/2006	US20060225146 Canola cultivar NQC02CNX21
10/05/2006	US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes
10/05/2006	US20060223987 Neutrophil specific immunoglobulins for use in treatment and prevention of microbial infection
10/05/2006	US20060223778 Circular nucleic acid vectors, and methods for making and using the same
10/05/2006	US20060223754 Human TSLP polynucleotides
10/05/2006	US20060223183 Gamma irradiation of frozen feeder cells
10/05/2006	US20060223182 Device for producing autologous VEGF
10/05/2006	US20060223181 Method for separating hepatic progenitor cell
10/05/2006	US20060223180 Methods to mobilize progenitor/stem cells
10/05/2006	US20060223179 Differentiation of pluripotent embryonic stem cells
10/05/2006	US20060223178 Devices and methods for magnetic enrichment of cells and other particles
10/05/2006	US20060223177 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
10/05/2006	US20060223176 Integrated system for on-site cell acquisition, processing, and delivery
10/05/2006	US20060223174 For culturing cells on removable membranes/sponges for the purpose of transplantation
10/05/2006	US20060223164 Microfluidic systems for altering the solution environment around a nanoscopic or microscopic object, such as a sensor; applied in any sensor technology in which the sensing element needs to be exposed rapidly, sequentially, and controllably, to a large number of different solution environments
10/05/2006	US20060223155 Enhancement of in vitro culture or vaccine production in bioreactors using electromagnetic energy
10/05/2006	US20060223144 Method for mass production of human pollicle stimulating hormone
10/05/2006	US20060223142 Extended cDNAs for secreted proteins
10/05/2006	US20060223133 Comprises immunoglobulin for treating arteriosclerosis, cancer and skin disorders; immunoassays; restenosis
10/05/2006	US20060223106 Early-stage multipotential stem cells in colonies of bone marrow stromal cells
10/05/2006	US20060223082 Map
10/05/2006	US20060223050 Therapeutic platelets and methods
10/05/2006	US20060222665 Virus vaccine
10/05/2006	US20060222663 Circovirus sequences associated with piglet weight loss disease (PWD)
10/05/2006	US20060222661 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
10/05/2006	US20060222649 Methods for inducing antigen-specific T cell tolerance
10/05/2006	US20060222644 Humanized anti-Lymphotoxin beta receptor antibodies
10/05/2006	US20060222636 Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells
10/05/2006	US20060222635 Methods and compositions for selecting cells with increased potency
10/05/2006	US20060222634 Amnion-derived cell compositions, methods of making and uses thereof
10/05/2006	US20060222590 Directed complementation
10/05/2006	US20060222589 Directed complementation
10/05/2006	DE102005059371A1 Controlled-release multifunctional seed capsule contains further capsules timed to release seed material, fertilizer, growth promoters and essential chemicals at the right time
10/05/2006	CA2605160A1 Clostridial toxin activity assays
10/05/2006	CA2603646A1 Supplementation for embryo and/or cell manipulation
10/05/2006	CA2603391A1 A human immortalised neural precursor cell line
10/05/2006	CA2603116A1 Controlling stem cell destiny with tunable network
10/05/2006	CA2603052A1 Immunogenic egfr peptides comprising foreign t cell stimulating epitope
10/05/2006	CA2602684A1 Amnion-derived cell compositions, methods of making and uses thereof
10/05/2006	CA2602337A1 Eg1117 and eg307 polynucleotides and uses thereof
10/05/2006	CA2601679A1 Preparation of autologous haematopoietic stem cells, the methods of production, cyropreservation and use for therapy of traumatic diseases of the central nervous system
10/05/2006	CA2598029A1 Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
10/05/2006	CA2593559A1 Polynucleotides encoding stem cell factor-like proteins
10/04/2006	EP1707631A2 An improved method for the production and purification of adenoviral vectors
10/04/2006	EP1707629A1 Expression system with the use of mammalian beta-actin promoter
10/04/2006	EP1707625A1 Process for producing hematopoietic stem cells or vascular endothelial precursor cells
10/04/2006	EP1707576A1 Antibodies recognizing methyllysine, process for producing the same and utilization thereof
10/04/2006	EP1706498A2 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
10/04/2006	EP1706491A2 Toxin complex proteins and genes from xenorhabdus bovienii
10/04/2006	EP1706486A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
10/04/2006	EP1706485A1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS
10/04/2006	EP1706484A2 Müller stem cells
10/04/2006	EP1706483A2 Methods for culturing keratinocytes from human embryonic stem cells
10/04/2006	EP1706428A2 Anti-cancer antibodies with reduced complement fixation
10/04/2006	EP1706426A2 Nogoa antibodies for the treatment of alzheimer disease
10/04/2006	EP1706425A2 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse®
10/04/2006	EP1706157A2 Method for the production of intervertebral disk tissue from degenerate intervertebral disk tissue
10/04/2006	EP1706153A1 Minimal lentiviral vector system
10/04/2006	EP1706145A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment
10/04/2006	EP1706103A2 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix
10/04/2006	EP1705992A1 Intratumoral delivery of dendritic cells
10/04/2006	EP1664300A4 A new class of a2delta calcium channel subunits
10/04/2006	EP1539929A4 Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
10/04/2006	EP1465475B1 Orobanche resistant sunflowers
10/04/2006	EP1402048A4 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
10/04/2006	EP1248640B1 Preparation and xenotransplantation of porcine islets
10/04/2006	EP1242595B1 Promoter and intron from maize actin depolymerizing factor
10/04/2006	EP1162996B1 Hapten-conjugated mammalian cells and methods of making and using thereof
10/04/2006	EP1161537B1 Non-spreading pestivirus
10/04/2006	EP1109918B1 Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof
10/04/2006	EP1083223B1 Novel immortalized hepatic cell line originating in humans
10/04/2006	EP1082435B1 Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/04/2006	EP1027375B1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
10/04/2006	EP1015577B8 Chromosomal mutagenesis in pichia methanolica
10/04/2006	EP1009832B1 Cytokine designated lerk-6

1 ... 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 ... 1827